课题基金 / 基金详情

IN VIVO IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN

IN VIVO IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN
人脑中挥发性麻醉作用 5HT2A 受体的体内成像
批准号:
6245708
负责人:
LEONARD FIRESTONE
金额:
$1.76万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-18 至 1997-11-30

项目摘要

项目成果

LEONARD FIRESTONE的其他基金

相似基金

相关文献

中文摘要
翻译
挥发性全身麻醉药的作用机制尚不清楚。其中一个 挥发性全麻药的假定靶点是大脑中的5-羟色胺 受体。这项研究将检验5HT2a受体的假设 不会表现出麻醉后的构象变化。的约束性 放射性示踪剂18F-Altanserin将在存在的情况下用PET测量 异氟醚的麻醉浓度与异氟醚的麻醉浓度 缺席将会被比较。
英文摘要
The mechanisms of volatile general anesthetics remain unclear. One of the putative targets for volatile general anesthetics is the brain serotonin receptor. This study will test the hypothesis that the 5HT2A receptor will not show a conformational change from anesthesia. The binding of the radiotracer 18F-altanserin will be measured by PET in the presence of an anesthetizing concentration of isoflurane to that in isoflurane's absence will be compared.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IN VIVO PET IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN
DO VOLATILE ANESTHETICS MODULATE BENZODIAZEPINE BINDING TO CEREBRAL NEURONS
DO VOLATILE ANESTHETICS MODULATE BENZODIAZEPINE BINDING TO CEREBRAL NEURONS
IN VIVO PET IMAGING OF VOLATILE ANESTHETIC ACTION 5HT2A RECEPTOR IN HUMAN BRAIN
海外基金